These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4117434)

  • 1. Pills for the benign prostate.
    Franks LM
    Proc R Soc Med; 1972 Feb; 65(2):125-6. PubMed ID: 4117434
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of orchiectomy and estrogens of benign prostatic hyperplasia.
    Wendel EF; Brannen GE; Putong PB; Grayhack JT
    J Urol; 1972 Jul; 108(1):116-9. PubMed ID: 4113691
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonsurgical treatment of human benign prostatic hyperplasia.
    Scott WW; Coffey DS
    Vitam Horm; 1975; 33():439-65. PubMed ID: 59463
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hormonal treatment benign prostatic hyperplasia. A review].
    Schoonees R; de Klerk JN
    S Afr Med J; 1972 Sep; 46(37):1337-9. PubMed ID: 4118059
    [No Abstract]   [Full Text] [Related]  

  • 5. The rationale of treating benign prostatic hypertrophy with combinations of testosterone and estrogen.
    GLASS SJ
    J Am Geriatr Soc; 1956 Apr; 4(4):358-64. PubMed ID: 13306513
    [No Abstract]   [Full Text] [Related]  

  • 6. [Conference on the treatment of cancer of the prostate].
    Richaud C
    J Urol Nephrol (Paris); 1968; 74(10):769-87. PubMed ID: 4178295
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical treatment of benign prostatic hyperplasia: the effect of surgical or medical castration.
    Schröder FH
    Prog Clin Biol Res; 1994; 386():191-6. PubMed ID: 7528386
    [No Abstract]   [Full Text] [Related]  

  • 8. [Nuclear content of deoxyribonucleic acid in the epithelium of hypertrophic prostate and prostatic carcinoma].
    Yamauchi A
    Nihon Hinyokika Gakkai Zasshi; 1970 Dec; 61(12):1170-83. PubMed ID: 4099311
    [No Abstract]   [Full Text] [Related]  

  • 9. Estrogenic management of benign prostatism, including early and poor-risk cases. 7-year experience.
    Roberts HJ
    J Am Geriatr Soc; 1966 Jul; 14(7):657-701. PubMed ID: 4160996
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostatic hyperplasia and neoplasia in female Praomys (Mastomys) natalensis.
    Holland JM
    J Natl Cancer Inst; 1970 Dec; 45(6):1229-36. PubMed ID: 4098904
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pathology of benign and malignant prostatic tumors].
    Dhom G
    Urologe A; 1992 Nov; 31(6):W47-55. PubMed ID: 1281358
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of insulin and testosterone in prostatic growth: who is doing what?
    Vikram A; Jena G
    Med Hypotheses; 2011 Apr; 76(4):474-8. PubMed ID: 21159446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electron microscopical studies on the prostatic epithelium. II. Fine structures of the human prostatic cancer.
    Kudo S
    Kumamoto Med J; 1967 Jun; 20(2):86-101. PubMed ID: 4169368
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prostatic adenoma--prostatic carcinoma. Questions from general practice. II. Therapy].
    Strohmenger P
    ZFA (Stuttgart); 1980 Oct; 56(28):1793-7. PubMed ID: 6162291
    [No Abstract]   [Full Text] [Related]  

  • 15. Morphological criteria for the control of carcinoma of the prostate with estrogen therapy.
    Ziegler H; Völter D; Schubert GE
    Int Urol Nephrol; 1974; 6(3-4):195-200. PubMed ID: 4142482
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: histological changes of minimally invasive procedures for the treatment of benign prostatic hyperplasia and prostate cancer: clinical implications.
    Kumar H
    J Urol; 2004 Mar; 171(3):1244. PubMed ID: 14767319
    [No Abstract]   [Full Text] [Related]  

  • 17. 5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium.
    Thomas LN; Douglas RC; Vessey JP; Gupta R; Fontaine D; Norman RW; Thompson IM; Troyer DA; Rittmaster RS; Lazier CB
    J Urol; 2003 Nov; 170(5):2019-25. PubMed ID: 14532845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular and endocrinological mechanism of benign prostatic hyperplasia and prostate cancer].
    Kinoshita H; Habuchi T; Ogawa O
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():23-7. PubMed ID: 12599539
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma.
    Mendoza P; Sánchez C; Contreras HR; Vergara J; Acevedo C; Cabezas J; Huidobro C; Noé G; Castellón EA
    Int J Androl; 2009 Dec; 32(6):607-15. PubMed ID: 18637152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Testosterone induces different-featured prostate hyperplasia in castrated and uncastrated mice].
    Sun WG; Gan LP; Yu GQ; Ye ZQ; Mi ZG; Wang QH; Han CZ; Ren LS; Wang HZ
    Zhonghua Nan Ke Xue; 2009 Feb; 15(2):153-7. PubMed ID: 19323377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.